Exploring the co‐activity of FDA approved drug gemcitabine and docetaxel for enhanced anti‐breast cancer activity: DFT, docking, molecular dynamics simulation and …

S Sukumaran, A Zochedh, K Chandran… - … Journal of Quantum …, 2024 - Wiley Online Library
Combining FDA‐approved medications may increase biological activity by simultaneously
targeting many protein mechanisms while being less toxic. Gemcitabine and docetaxel …

Reduction‐Responsive RGD‐Docetaxel Conjugate: Synthesis, In Vitro Drug Release and In Vitro Antitumor Activity

Q Li, Y Liu, Y Cheng, H Cao, K Du… - Drug Development …, 2025 - Wiley Online Library
Poor selectivity to tumor cells is a major drawback in the clinical application of the antitumor
drug docetaxel (DTX). Peptide–drug conjugates (PDCs) constructed by modifying antitumor …